hypogammaglobulinaemia. Septic arthritis forms a well recognised subgroup. Aseptic, non-erosive chronic polyarthritis, distinct from rheumatoid arthritis (RA), has also been described.' 2 A 72-year-old female presented with a painful swollen right wrist when aged 57. A synovectomy was performed, and histological examination showed chronic inflammatory changes consistent with RA. Over the next two years the disease progressed to affect her shoulders, wrists, and knee joints. Tests for rheumatoid factor were presistently negative and the ESR was initially raised at 50mm/h. Gold was started at 10 mg/week and continued at 20 mg/week. Chrysotherapy was stopped after she had received 3000 mg, when she was admitted to Both patients received parenteral gold, with benefit in case 2, until they were admitted to hospital with acute respiratory illnesses. In the light of these unusual clinical features we feel that gold therapy is the most likely cause of hypogammaglobulinaemia, and their respiratory illness may be a concurrent manifestation of toxicity to gold. Serum immunoglobulins were not measured at the onset to allow precise identification of development of immunodeficiency in relation to treatment, but indirect evidence from total serum globulins indicated that the fall occurred after the introduction of gold therapy.
Gold therapy is known to depress serum immunoglobulin levels in patients with classical RA and juvenile chronic arthritis.6 In adult RA the maximal suppression is in IgM, which is apparent six months after starting therapy. The duration of suppression may be for up to four years. 4 
